• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从大脑中分离并鉴定出一种能抑制1,4-[3H]二氢吡啶结合和L型钙通道电流的组分。

Isolation and characterization of a fraction from brain that inhibits 1,4-[3H]dihydropyridine binding and L-type calcium channel current.

作者信息

Janis R A, Shrikhande A V, Johnson D E, McCarthy R T, Howard A D, Greguski R, Scriabine A

机构信息

Institute for Preclinical Pharmacology, Miles Inc., West Haven, CT 06516.

出版信息

FEBS Lett. 1988 Nov 7;239(2):233-6. doi: 10.1016/0014-5793(88)80923-2.

DOI:10.1016/0014-5793(88)80923-2
PMID:2846356
Abstract

Bovine brain was subjected to acid extraction and several purification steps. A fraction from brain that eluted from C18 reverse-phase columns at 30-35% acetonitrile inhibited [3H]nitrendipine binding to cardiac membranes. Further purification of this fraction on a sizing column in the presence of 40% acetonitrile yielded a low molecular mass fraction (less than 1 kDa) that produced a time- and voltage-dependent inhibition of L-type (but not T-type) Ca2+-channel current in GH3 cells. The results suggest that this fraction contains an endogenous substance that binds directly to slowly-inactivating Ca2+ channels and thereby inhibits current flow.

摘要

牛脑经过酸提取和多个纯化步骤。从C18反相柱上以30 - 35%乙腈洗脱的脑部分馏物可抑制[3H]尼群地平与心肌膜的结合。在40%乙腈存在下,将该部分馏物在尺寸排阻柱上进一步纯化,得到一个低分子量部分馏物(小于1 kDa),该部分馏物对GH3细胞中的L型(而非T型)Ca2 +通道电流产生时间和电压依赖性抑制。结果表明,该部分馏物含有一种内源性物质,它直接与缓慢失活的Ca2 +通道结合,从而抑制电流流动。

相似文献

1
Isolation and characterization of a fraction from brain that inhibits 1,4-[3H]dihydropyridine binding and L-type calcium channel current.从大脑中分离并鉴定出一种能抑制1,4-[3H]二氢吡啶结合和L型钙通道电流的组分。
FEBS Lett. 1988 Nov 7;239(2):233-6. doi: 10.1016/0014-5793(88)80923-2.
2
Local anesthetics differentiate dihydropyridine calcium antagonist binding sites in rat brain and cardiac membranes.局部麻醉药可区分大鼠脑和心肌膜中的二氢吡啶钙拮抗剂结合位点。
J Pharmacol Exp Ther. 1987 Mar;240(3):922-30.
3
Separate binding and functional sites for omega-conotoxin and nitrendipine suggest two types of calcium channels in bovine chromaffin cells.ω-芋螺毒素和尼群地平的独立结合位点与功能位点表明牛嗜铬细胞中存在两种类型的钙通道。
J Neurochem. 1989 Oct;53(4):1050-6. doi: 10.1111/j.1471-4159.1989.tb07394.x.
4
Purification and characterization of an endogenous protein modulator of radioligand binding to "peripheral-type" benzodiazepine receptors and dihydropyridine Ca2+-channel antagonist binding sites.一种内源性蛋白质调节剂的纯化与特性研究,该调节剂可调节放射性配体与“外周型”苯二氮䓬受体及二氢吡啶钙通道拮抗剂结合位点的结合。
Biochem Pharmacol. 1988 Jan 15;37(2):339-47. doi: 10.1016/0006-2952(88)90738-1.
5
Substituted diphenylbutylpiperidines bind to a unique high affinity site on the L-type calcium channel. Evidence for a fourth site in the cardiac calcium entry blocker receptor complex.取代的二苯基丁基哌啶与L型钙通道上一个独特的高亲和力位点结合。心脏钙通道阻滞剂受体复合物中第四个位点的证据。
J Biol Chem. 1989 Apr 5;264(10):5633-41.
6
Selective inhibition of [3H]nitrendipine binding to brain and cardiac membranes by bacitracin.杆菌肽对[3H]尼群地平与脑及心脏膜结合的选择性抑制作用。
Can J Physiol Pharmacol. 1989 Dec;67(12):1591-5. doi: 10.1139/y89-255.
7
Characterization of calcium antagonist receptors in highly purified porcine cardiac sarcolemma.
Biomed Biochim Acta. 1987;46(8-9):S363-9.
8
Separate [3H]-nitrendipine binding sites in mitochondria and plasma membranes of bovine adrenal medulla.牛肾上腺髓质线粒体和质膜中[3H]-尼群地平结合位点的分离。
Br J Pharmacol. 1990 Sep;101(1):21-6. doi: 10.1111/j.1476-5381.1990.tb12082.x.
9
Mitochondrial Ca2+ antagonist binding sites are associated with an inner mitochondrial membrane anion channel.线粒体钙离子拮抗剂结合位点与线粒体内膜阴离子通道相关。
Mol Pharmacol. 1990 Sep;38(3):362-9.
10
Identification, characterization, and photoaffinity labeling of the dihydropyridine receptor associated with the L-type calcium channel from bovine adrenal medulla.牛肾上腺髓质L型钙通道相关二氢吡啶受体的鉴定、表征及光亲和标记
Mol Pharmacol. 1990 Feb;37(2):173-81.